{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:21:49Z","timestamp":1763018509817},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anemia and iron deficiency (ID) are common in patients with heart failure (HF) and intravenous (IV) administration of iron to patients hospitalized for decompensated HF with ID improves outcome. The diagnosis of ID in routine practice is based on serum ferritin and transferrin saturation (TSAT) but both have limitations; alternatives should be considered. Reticulocyte hemoglobin equivalent (Ret-He) reflects iron content in reticulocytes but its clinical utility in patients with HF remains uncertain. We prospectively enrolled 142 patients hospitalized for decompensated HF. Sixty five percent had ID as defined in current international guidelines. Ret-He was directly correlated with serum iron and ferritin concentrations and with TSAT. There was a poor relationship between quartile of Ret-He and HF hospitalization or death but increases or decreases in Ret-He between admission and discharge were associated with a worse outcome. The clinical utility of Ret-He for identifying ID and predicting response to IV iron and prognosis for patients with HF requires further investigation.<\/jats:p>","DOI":"10.1038\/s41598-022-18192-x","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T14:05:17Z","timestamp":1660745117000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical utility of reticulocyte hemoglobin equivalent in patients with heart failure"],"prefix":"10.1038","volume":"12","author":[{"given":"Saki","family":"Tahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiki","family":"Yasumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Horimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Sunayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Masai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Duk","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"18192_CR1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","volume":"52","author":"HF Groenveld","year":"2008","unstructured":"Groenveld, H. F. et al. Anemia and mortality in heart failure patients: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 52, 818\u2013827 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"18192_CR2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00380-019-01349-6","volume":"34","author":"K Okuno","year":"2019","unstructured":"Okuno, K. et al. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: Results of the Japanese heart failure syndrome with preserved ejection fraction registry. Heart Vessels. 34, 1168\u20131177 (2019).","journal-title":"Heart Vessels."},{"key":"18192_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","volume":"71","author":"BML Rocha","year":"2018","unstructured":"Rocha, B. M. L., Cunha, G. J. L. & Menezes Falc\u00e3o, L. F. The burden of iron deficiency in heart failure: Therapeutic approach. J. Am. Coll. Cardiol. 71, 782\u2013798 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"18192_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ejhf.84","volume":"16","author":"IT Klip","year":"2014","unstructured":"Klip, I. T. et al. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences. Eur. J. Heart Fail. 16, 655\u2013662 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"18192_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip, I. T. et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am. Heart J. 165, 575-582.e3 (2013).","journal-title":"Am. Heart J."},{"key":"18192_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","volume":"48","author":"JN Nanas","year":"2006","unstructured":"Nanas, J. N. et al. Etiology of anemia in patients with advanced heart failure. J. Am. Coll. Cardiol. 48, 2485\u20132489 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"18192_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh, T. A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599\u20133726 (2021).","journal-title":"Eur. Heart J."},{"key":"18192_CR8","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. (2022) AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation 145, e895\u2013e1032 (2022).","journal-title":"Circulation"},{"key":"18192_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejim.2012.09.001","volume":"24","author":"E Joosten","year":"2013","unstructured":"Joosten, E., Lioen, P., Brusselmans, C., Indevuyst, C. & Boeckx, N. Is analysis of the reticulocyte haemoglobin equivalent a useful test for the diagnosis of iron deficiency anaemia in geriatric patients?. Eur. J. Intern. Med. 24, 63\u201366 (2013).","journal-title":"Eur. J. Intern. Med."},{"key":"18192_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2257.2006.00812.x","volume":"28","author":"C Brugnara","year":"2006","unstructured":"Brugnara, C., Schiller, B. & Moran, J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin. Lab Haematol. 28, 303\u2013308 (2006).","journal-title":"Clin. Lab Haematol."},{"key":"18192_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12185-017-2212-6","volume":"106","author":"Y Toki","year":"2017","unstructured":"Toki, Y. et al. Reticulocyte hemoglobin equivalent as a potential marker for diagnosis of iron deficiency. Int. J. Hematol. 106, 116\u2013125 (2017).","journal-title":"Int. J. Hematol."},{"key":"18192_CR12","first-page":"9","volume":"405","author":"World Health Organization Nutritional anaemias","year":"1968","unstructured":"World Health Organization Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech. Rep. Ser. 405, 9\u201310 (1968).","journal-title":"WHO Tech. Rep. Ser."},{"key":"18192_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","volume":"1","author":"JG Cleland","year":"2016","unstructured":"Cleland, J. G. et al. Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiol. 1, 539\u2013547 (2016).","journal-title":"JAMA Cardiol."},{"key":"18192_CR14","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker, S. D. et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 361, 2436\u20132448 (2009).","journal-title":"N. Engl. J. Med."},{"key":"18192_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen, D. J. et al. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation 136, 1374\u20131383 (2017).","journal-title":"Circulation"},{"key":"18192_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski, P. et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur. Heart J. 36, 657\u2013668 (2015).","journal-title":"Eur. Heart J."},{"key":"18192_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"G Masini","year":"2022","unstructured":"Masini, G. et al. Criteria for iron deficiency in patients with heart failure. J. Am. Coll. Cardiol. 79, 341\u2013351 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"18192_CR18","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","volume":"285","author":"PA McKee","year":"1971","unstructured":"McKee, P. A. et al. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med. 285, 1441\u20131446 (1971).","journal-title":"N. Engl. J. Med."},{"key":"18192_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski, P. et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396, 1895\u20131904 (2020).","journal-title":"Lancet"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18192-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18192-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:23:01Z","timestamp":1669360981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18192-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18192"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18192-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13978"}}